Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.36 is 11% below its 1-year average of 1.52, near the low end of its 1-year range (1.36–1.68).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.36.
CURRENT RATIO
1.36
CURRENT RATIO AVG TTM
N/A
CURRENT RATIO AVG 3Y
N/A
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
-63.87%
vs the sector median at left
Market Cap
$656.59M
Current Ratio
8.03
TTM Avg
12.16
3Y Avg
13.50
5Y Avg
14.42
Market Cap
$638.20M
Current Ratio
16.82
TTM Avg
9.46
3Y Avg
14.12
5Y Avg
14.05
Market Cap
$681.27M
Current Ratio
13.82
TTM Avg
5.67
3Y Avg
7.51
5Y Avg
7.66
Market Cap
$634.30M
Current Ratio
5.17
TTM Avg
4.10
3Y Avg
4.28
5Y Avg
7.57
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Starling Oncology, Inc. (STLN) | $657.89M | 1.36 | N/A | N/A | N/A |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $656.59M | 8.03 | 12.16 | 13.50 | 14.42 |
| Annexon, Inc. (ANNX)vs › | $660.29M | 5.53 | 8.02 | 10.47 | 14.43 |
| Helus Pharma Inc. (HELP)vs › | $666.95M | 10.97 | 8.63 | 10.75 | 10.66 |
| MiMedx Group, Inc. (MDXG)vs › | $673.41M | 5.33 | 4.27 | 3.79 | 3.57 |
| Aura Biosciences, Inc. (AURA)vs › | $638.20M | 16.82 | 9.46 | 14.12 | 14.05 |
| Verastem, Inc. (VSTM)vs › | $681.02M | 2.25 | 3.08 | 3.98 | 5.01 |
| Solid Biosciences Inc. (SLDB)vs › | $681.27M | 13.82 | 5.67 | 7.51 | 7.66 |
| Zevra Therapeutics, Inc. (ZVRA)vs › | $634.30M | 5.17 | 4.10 | 4.28 | 7.57 |
| Prime Medicine, Inc. (PRME)vs › | $632.16M | 3.05 | 5.21 | 6.01 | 5.25 |
Current Ratio
1.36
Quick Ratio
1.15
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.36 |
| 2026-03-31 | 1.47 |
| 2025-12-31 | 1.59 |
| 2025-09-30 | 1.68 |
